NL-OMON21725尚未招募不适用
Clinical vaccine efficacy and clinical effectiveness of oseltamivir in reducing Influenza related complications in patients with a solid organ transplant.
none0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Admission in a hospital within the Leiden Transplantation Region with laboratory confirmed Influenza A or B infection or with a diagnostic test for respiratory virus infection in solid organ recipient (kidney, liver, pancreas or combination) between October 2013 and March 2020 (end of flu season 2020)
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Studies on effectiveness and safety of vaccination with H5N1 prepandemic vaccines, and cross-immunity among H5N1 virusesJPRN-UMIN000024388Fujita Health University200
已完成
3 期
Sub lingual immunotherapy of Nasal allergiesPerennial allergic rhinitis.Other allergic rhinitisIRCT2017042323235N9Vice chancellor for research, Mashhad University of Medical Sciences40
进行中(未招募)
1 期
Clinical efficacy, immunogenicity, clinical tolerability and assessment of safety of gpASIT+TM administered orally, according to two administration schedules, for the prophylaxis of seasonal grass pollen rhinoconjunctivitis - Not availableTreatment of seasonal grass pollen rhinoconjunctivitisMedDRA version: 12.1Level: LLTClassification code 10019170Term: Hay feverEUCTR2010-023176-12-BEBiotech Tools sa414
已完成
不适用
Preventive effectiveness and safety of vaccination against nosocomial outbreaks of COVID-19JPRN-UMIN000043534Tsukuba Memorial Hospital1,030
进行中(未招募)
1 期
Therapeutic vaccination: Phase I / II clinical study on patients randomized blinded to the experimental vaccine or placebo regimen. we want to evaluate the safety and the immunogenicity of a vaccine that includes a first administration of theChAdOx1.tHIVconsvX product and a second one with MVA.tHIVconsvX in HIV-1 positive adults treated early and able to control the infection for a long time.HIV InfectionCTIS2024-514581-39-00Ospedale San Raffaele S.r.l.33
